Integra LifeSciences Holdings (IART) remains unprofitable, with losses accelerating at a 59% per year pace over the last five years. Revenue is forecast to grow just 2.5% annually, trailing the ...

If you’re trying to figure out your next move with Integra LifeSciences Holdings, you’re not alone. With the stock closing at $15.08 recently, a lot of investors are watching the chart closely and ...

Acura's most affordable model—and only remaining car—sees a light upgrade with a corresponding lift in pricing. The 2026 Acura Integra has begun arriving in dealerships, and Acura has released ...

Acura reintroduced the Integra to the United States market in 2022 for the 2023 model year. Produced in Ohio with Civic underpinnings, the premium-oriented liftback is entering the 2026 model year ...

2026 Acura Integra models will now sport a standard 9.0-inch touchscreen media controller. Integra A-Spec models will receive a redesigned body kit and a new set of 18-inch wheels. Acura says the 2026 ...

View post: 2025 Nissan Ariya vs 2025 Ford Mustang Mach-E: Which Is the Better Buy? Besides a few grievances about it having an extra pair of doors and sharing its standard 1.5-liter engine with the ...

The modern Acura Integra is not exactly a two-door liftback like the beloved Type R coupes of the past, but the five-door hatchback is still a great value that mixes the simple strengths of the ...

The Acura Integra returned in 2022 as a Civic-based liftback that blended practicality with luxury. It’s been well-received by customers, and Americans snapped up 24,398 of these last year. That meant ...

Last year was a trying time for Integra LifeSciences. The Princeton, NJ-based company suffered from quality control issues, which led to the firm lowering its full-year guidance. Now the company has ...

Integra LifeSciences had a rough 2024 as the company's quality control remediation efforts had a bigger than expected negative impact on results. Q4 '24 offered some stability with organic revenue ...

Integra Resources has faced poor stock performance due to negative sentiment and suboptimal financings but now holds a promising asset portfolio including DeLamar, Nevada North, and Florida Canyon.